Dosimetric factors associated with long-term patient-reported outcomes after definitive radiotherapy of patients with head and neck cancer.
Toyokazu HayakawaShogo KawakamiItaru SodaTakuro KainumaMarika NozawaAkane SekiguchiShunsuke MiyamotoTaku YamashitaHiromichi IshiyamaPublished in: Radiation oncology (London, England) (2019)
We found that dosages to the SPC and parotid gland were associated with severe deterioration in HRQOL attributable to difficulty in HNSO and HNCO, whereas dosage to the MPC was associated with severe deterioration attributable to nausea and vomiting.